BackKyverna Therapeutics Overview

Kyverna Therapeutics Accounts Payable

Latest accounts payable for KYTX: $2.9M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$2.93M
↓ 70.42% YoYΔ $-6.98M vs prior year quarter

Peer trimmed avg / median

Loading

Kyverna Therapeutics Accounts Payable History

Loading

Kyverna Therapeutics vs. peers: Accounts Payable Comparison

Loading

Kyverna Therapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kyverna Therapeutics (KYTX) FAQ

As of the most recent data (June 2026), KYTX shows a accounts payable of $2.9M. That compares with $9.9M in the prior-year period — down 70.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KYTX's accounts payable is now $2.9M (was $9.9M) — a 70.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Kyverna Therapeutics is outperforming or lagging.

Tracking KYTX's accounts payable over time shows whether Kyverna Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.9M That compares with $9.9M in the prior-year period — down 70.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Kyverna Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.9M) with ownership activity and broader fundamentals.